Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.

Daniel J LandsburgMitchell E HughesAlexa KoikeDavid BondKami J MaddocksLing GuoAllison M WinterBrian T HillSarah L OndrejkaEric D HsiSunita D NastaJakub SvobodaStephen J SchusterAgata M Bogusz

Published in: Blood advances (2020)

Keyphrases

diffuse large b cell lymphoma
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
combination therapy
open label
chronic lymphocytic leukemia
randomized controlled trial
newly diagnosed
adipose tissue
insulin resistance